Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-01

Clinical Trial Update: Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application [NA]

View source ↗

Summary

The update reports cosmetic outcomes of Leishmaniasis scars after topical WR279396 in a completed clinical trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • WR279396

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Cutaneous Leishmaniasis, Scar | NA | Status: COMPLETED